Jiayu Liu School of Pharmaceutical Sciences Sun Yat-Sen University Biography Publications Institution JoVE Articles Jiayu Liu has not added a biography. If you are Jiayu Liu and would like to personalize this page please email our Author Liaison for assistance. Publications A HER2 Bispecific Antibody Can Be Efficiently Expressed in with Potent Cytotoxicity Oncology Letters. Jul, 2018 | Pubmed ID: 29963199 Site-specific PEGylation of an Anti-CEA/CD3 Bispecific Antibody Improves Its Antitumor Efficacy International Journal of Nanomedicine. 2018 | Pubmed ID: 29881272 A Single Domain-Based Anti-Her2 Antibody Has Potent Antitumor Activities Translational Oncology. Apr, 2018 | Pubmed ID: 29455083 Single Domain Based Bispecific Antibody, Muc1-Bi-1, and Its Humanized Form, Muc1-Bi-2, Induce Potent Cancer Cell Killing in Muc1 Positive Tumor Cells PloS One. 2018 | Pubmed ID: 29357376 A Bispecific Antibody Based on Pertuzumab Fab Has Potent Antitumor Activity Journal of Immunotherapy (Hagerstown, Md. : 1997). Jan, 2018 | Pubmed ID: 29232309 BiHC, a T-Cell-Engaging Bispecific Recombinant Antibody, Has Potent Cytotoxic Activity Against Her2 Tumor Cells Translational Oncology. Oct, 2017 | Pubmed ID: 28797938 A Targeted IL-15 Fusion Protein with Potent Anti-tumor Activity Cancer Biology & Therapy. 2015 | Pubmed ID: 26176990 GPC3-ориентация Bispecific антител, GPC3-S-Fab, с мощным цитотоксичности Yanlan Wang1,2, Jiayu Liu1,2, Haitao Pan1,2, Jieyu Xing1,2, Xiaoqiong Wu1,2, Qing Li1,2, Zhong Wang1,2 1School of Pharmaceutical Sciences, Sun Yat-Sen University, 2Center for Cellular & Structural Biology, Sun Yat-Sen University JoVE 57588 Cancer Research
GPC3-ориентация Bispecific антител, GPC3-S-Fab, с мощным цитотоксичности Yanlan Wang1,2, Jiayu Liu1,2, Haitao Pan1,2, Jieyu Xing1,2, Xiaoqiong Wu1,2, Qing Li1,2, Zhong Wang1,2 1School of Pharmaceutical Sciences, Sun Yat-Sen University, 2Center for Cellular & Structural Biology, Sun Yat-Sen University JoVE 57588 Cancer Research
